Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03609203 · ClinicalTrials.gov registry record
Improving Self-Efficacy, Resolving Inflammaging Allo HSCT Survivors in Personal Training
A clinical trial, sponsored by Masonic Cancer Center, University of Minnesota.
- Completed
- Registry status
- 25
- Enrollment target
NCT03609203 is a clinical trial that has completed, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 25 participants.
The verdict
NCT03609203 has completed, sponsored by Masonic Cancer Center, University of Minnesota.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
This protocol is a pilot study of a personalized and supervised 10-week strength training program to improve self-efficacy and resolve biomarkers of inflammaging in a cohort of allogeneic hematopoietic transplant (HCT) long-term survivors versus healthy controls.
Interventions
- OTHER 10 Weeks of Strength Trailing
- OTHER Group Nutrition Discussion: week 1, week 5 and week 10
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2018-09-10 |
| Est. Completion | 2021-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03609203
The ClinicalTrials.gov registry entry for NCT03609203 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masonic Cancer Center, University of Minnesota, which has 249 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 10 Weeks of Strength Trailing is the first listed.
NCT03609203 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03609203 about?
NCT03609203 is a clinical study titled "Improving Self-Efficacy, Resolving Inflammaging Allo HSCT Survivors in Personal Training". This protocol is a pilot study of a personalized and supervised 10-week strength training program to improve self-efficacy and resolve biomarkers of inflammaging in a cohort of allogeneic hematopoietic transplant (HCT) long-term survivors versus healthy controls.
What is the current status of trial NCT03609203?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2018-09-10. Estimated completion is 2021-03-31.
What interventions are being tested in trial NCT03609203?
The interventions under investigation include: 10 Weeks of Strength Trailing (OTHER), Group Nutrition Discussion: week 1, week 5 and week 10 (OTHER).
Who is sponsoring clinical trial NCT03609203?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.